BNP Paribas acquires Exane

Following a recent announcement in March 2021, BNP Paribas has received all the necessary approvals and completed the acquisition of 100% of Exane.

Following a recent announcement in March 2021, BNP Paribas has received all the necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership.

This milestone represents a new chapter for BNP Paribas and Exane, thanks to the strong collaboration from the teams of both firms. The acquisition enables the bank to fully leverage Exane’s expertise in cash equities (execution and research) and derivatives, offering to institutional investors and corporates globally a full suite of services and solutions on equities.

The acquisition of Exane, together with the transfer of Deutsche Bank’s Global Prime Finance and Electronic Equities business to BNP Paribas, positions BNP Paribas as a European leader in Global Equities. It also supports CIB’s ambition in Equity Capital Markets and M&A.

Yann Gérardin, Head of Corporate & Institutional Banking, and Chief Operating Officer, BNP Paribas

Exane plays a key role in BNP Paribas Global Markets’ fully-fledged equity ambition as we bring in cash equities, while continuing to strengthen our flow and derivatives offerings, and expanding the prime services business through the new integrated platform from Deutsche Bank. We look forward to welcome our Exane colleagues to the bank.

Olivier Osty, Head of Global Markets, BNP Paribas
The category

The post title

The excerpt

Related solutions

Global Markets

BNP Paribas’ Global Markets offers consistent client service and innovative solutions for investment, hedging and financing opportunities across asset classes and geographies, as well as cross-asset strategy and economics to help our clients make informed decisions.

Cash Equities

BNP Paribas’ best-in-class Cash Equities platform offers award-winning equity research and a premier, customisable execution experience. BNP Paribas Exane research is renowned for its depth and quality, reinforced by experienced, top-ranked sales and specialist teams as well as a dedicated corporate access service. This, combined with our market-leading global execution services including Cortex Equities, a state-of-the-art electronic trading platform, high-touch trading, portfolio trading, quant research and execution consulting deliver an unparalleled Cash Equities offering.

Equity Derivatives

BNP Paribas has over 30 years of track record in developing innovative equity derivatives strategies and is an established global leader in structured products. Our comprehensive range of solutions across flow and structured products is designed to meet all our clients’ needs.

Global Equities

Building on our long-established world-class Equity Derivatives business, BNP Paribas continues to diversify and scale our Equities offering. Clients can now access the combined strengths of our market-leading Prime Services and Cash Equities platforms.